FENC

Fennec Pharmaceuticals Inc. - Common Stock (FENC)

About Fennec Pharmaceuticals Inc. - Common Stock (FENC)

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high

$8.92

Daily low

$8.40

Price at open

$8.85

52 Week High

$9.30

52 Week Low

$3.96

Market cap

233.2M

Dividend yield

0.00%

Volume

65,131

Avg. volume

74,002

P/E ratio

-16.42

Fennec Pharmaceuticals Inc. - Common Stock News